1. VanievEV, VasilyevaIA, AbdullaevRY, ChukanovVI, DaurovRB (2008). The use of fluoroquinolones in the intensive phase of treatment for newly diagnosed pa-tients with destructive lung tuberculosis [Ispol’zovanie ftorkhinolonov v intensivnoy faze lecheniya vpervye vyyavlennykh bol’nykh destruktivnym tuberkulezom legkikh]. Problemy tuberkuleza i bolezni legkikh, (10), 57-60.
2. GordinaAV, ZaychenkoNM, KucheryavayaDA, NechayevaOB, SonIM, SterlikovSA, OdintsovVE (2015). Resources and activity of anti-TB institutions of the Rus-sian Federation in 2013-2014 (statistical materials) [Re-sursy i deyatel’nost’ protivotuberkuleznykh organizatsiy Rossiyskoy Federatsii v 2013-2014 gg. (statisticheskie materialy)], 89
3. KelasovaNV, AksenovaVА (2007). The effectiveness of “Lomekomb” treatment of young patients with pulmo-nary tuberculosis [Effektivnost’ lecheniya preparatom «Lomekomb» molodykh bol’nykh tuberkulezom legkikh]. Vrach, (8), 32-33
4. KononetsAS, MishinVY (2008). The effectiveness of the treatment of newly diagnosed pulmonary tu-berculosis patients with high level of drug resistance [Effektivnost’ lecheniya vpervye vyyavlennykh bol’nykh tuberkulezom legkikh s vysokim urovnem razvitiya le-karstvennoy ustoychivosti vozbuditelya]. Infektsionnye bolezni, 6(4), 68-71
5. LevashovYN, MishinVY, KrasnovVA, StepanovDV, SvistelnikAV, SmerdinSV, MokhirevaLV (2009). Mul-ticenter study of the effectiveness of IIb chemotherapy mode with the use of combined drug “Lomekomb” in the treatment of patients with newly diagnosed MbT+ pulmonary tuberculosis [Mnogotsentrovye issledovaniya effektivnosti IIb rezhima khimioterapii s ispol’zovaniem kombinirovannogo preparata lomekomb pri lechenii vpervye vyyavlennykh bol’nykh tuberkulezom legkikh s bakteriovydeleniem]. Tezisy dokladov XVI Rossiyskogo natsional’nogo kongressa «Chelovek i lekarstvo», 157.
6. MishinVY (2007). Pulmonary tuberculosis with drug-resistant pathogen [Tuberkulez legkikh s lekarst-vennoy ustoychivost’yu vozbuditelya], 197.
7. MishinVY, MyakishevaTV, AmaraevaLV, An-drianovaAY, BorovitskiVS, LomovaLA, LuzinaNV, MishinaAV, OsintsevIY, ChurinaEG (2011). The effective-ness of treatment of patients with destructive pulmonary tuberculosis at parenteral and oral anti-TB drugs appli-cation [Effektivnost’ lecheniya bol’nykh destruktivnym tuberkulezom legkikh bol’nykh pri parenteral’nom i per-oral’nom primenenii protivotuberkuleznykh preparatov]. Pul’monologiya, (1), 55-59.
8. MishinVY (2014). On the contradictions in the Russian clinical recommendations for chemotherapy in pulmonary tuberculosis patients from the point of evidence-based medicine: meta-analysis and systematic review of literature [O protivorechiyakh v Rossiyskikh klinicheskikh rekomendatsiyakh po khimioterapii bol’nykh tuberkulezom legkikh s pozitsiy dokazatel’noy meditsiny: metaanaliz i sistematicheskiy obzor literatury]. Pul’monologiya, (4), 80-90.
9. OvsyankinaES, FirsovaVA, GubkinaMF, Kobulash-viliMG, OkhorzinaNA (2008). Regional lymphotropic injection of drugs in the differential diagnosis and complex treatment of tuberculosis in adolescents: Guidance Man-ual [Primenenie regional’nogo limfotropnogo vvedeniya lekarstvennykh preparatov v differentsial’noy diagnostike i kompleksnom lechenii tuberkuleza u podrostkov: Meto-dicheskoe posobie TsNIIT RAMN], 18
10. RabukhinAE (1970). Chemotherapy of pulmonary tuberculosis patients [Khimioterapiya bol’nykh tuberku-lezom legkikh], 400.
11. PerelmanMA (2007). Phthisiology. National guide-lines [Ftiziatriya. Natsional’noe rukovodstvo], 506.
12. Federal guidelines on the use of drugs (formulary sys-tem) (2016) [Federal’noe rukovodstvo po ispol’zovaniyu le-karstvennykh preparatov (formulyarnaya sistema)], 699-706.
13. KhomenkoAG (1980). Chemotherapy of pulmonary tuberculosis [Khimioterapiya tuberkuleza legkikh], 279.
14. ShilovaMV (2015). Tuberculosis in Russia in 2014 [Tuberkulez v Rossii v 2014 godu], 236.
15. Drug-resistant tuberculosis (2011). A survival guide for clinicians, 2nd ed., 266. Available at: http://www.currytbcenter.ucsf.edu/drtb/drtb_ch3.cfm
